Recombinant human tissue kallikrein clinical trials

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

This study is testing a new medicine, DM199, for people who have had a type of stroke called an ischaemic stroke. It aims to see if the medicine is safe and helps people recover better, especially those with fewer treatment options.